Wormentel 222 Mg contains Fenbendazole 222 mg, a broad-spectrum antiparasitic agent traditionally used in veterinary medicine. Its effectiveness against a wide range of intestinal parasites—such as roundworms, whipworms, hookworms, and some tapeworms—has made it a popular deworming option in animals. However, increasing interest in its off-label use for humans has raised important questions about its safety and efficacy.

Fenbendazole works by disrupting glucose uptake in parasites, effectively starving them and leading to their elimination from the body. When used in humans, anecdotal reports and preliminary studies suggest that it is generally well-tolerated in short courses, with few side effects. These may include mild nausea, flatulence, or occasional stomach discomfort. No serious adverse effects have been widely reported when used at moderate doses.

Though Wormentel 222 Mg has not been formally approved for human use by major regulatory authorities, it is cautiously being used by individuals seeking alternative deworming solutions. Additionally, it has gained attention for potential experimental uses in integrative cancer therapy, though such applications remain unproven and should only be considered under medical supervision.

In summary, while Wormentel 222 Mg shows promise for human use, medical guidance is essential before starting any off-label regimen.